Free Trial

Edesa Biotech (EDSA) Institutional Ownership

Edesa Biotech logo
$2.13 +0.09 (+4.41%)
Closing price 07/3/2025 03:56 PM Eastern
Extended Trading
$2.13 0.00 (0.00%)
As of 07/3/2025 04:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Edesa Biotech (NASDAQ:EDSA)

Current
Institutional Ownership
Percentage
5.50%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$5.09M
Number of
Institutional Sellers
(last 12 months)
0
Get EDSA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Edesa Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

EDSA Institutional Buying and Selling by Quarter

Edesa Biotech Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/15/2025Nantahala Capital Management LLC625,000$1.53M0.1%N/A8.899%
5/15/2025Velan Capital Investment Management LP687,500$1.68M1.7%N/A9.789%
5/14/2025Stonepine Capital Management LLC687,500$1.68M1.6%N/A9.789%
2/17/2025Citadel Advisors LLC40,944$70K0.0%N/A1.180%
2/14/2025Two Sigma Securities LLC15,313$26K0.0%N/A0.441%
8/2/2024CM Management LLC90,000$385K0.3%+45.2%2.795%
11/7/2023CM Management LLC417,602$264K0.3%+11.4%13.874%
8/4/2023CM Management LLC375,000$304K0.3%+15.4%1.821%
5/8/2023CM Management LLC325,000$296K0.4%+3.9%1.620%
2/14/2023Susquehanna International Group LLP15,211$33K0.0%N/A0.079%
2/9/2023CM Management LLC312,773$676K0.8%+25.1%1.616%
2/7/2023Lynwood Capital Management Inc.121,845$264K0.3%N/A0.630%
11/4/2022CM Management LLC250,000$230K0.3%N/A1.617%
8/8/2022Merit Financial Group LLC20,409$33K0.0%N/A0.132%
5/5/2022National Bank of Canada FI10,000$30K0.0%+1,518.1%0.072%
11/16/2021Verition Fund Management LLC13,502$100K0.0%N/A0.102%
10/28/2021180 Wealth Advisors LLC20,000$156K0.0%+33.3%0.151%
9/17/2021Virtu Financial LLC18,938$100K0.0%+17.4%0.143%
8/13/2021180 Wealth Advisors LLC15,000$70K0.0%N/A0.113%
8/13/2021Geode Capital Management LLC74,032$390K0.0%+153.3%0.558%
8/13/2021Vanguard Group Inc.109,158$576K0.0%+88.9%0.823%
5/19/2021Virtu Financial LLC16,138$87K0.0%N/A0.122%
5/12/2021Northern Trust Corp15,349$83K0.0%N/A0.116%
5/12/2021Geode Capital Management LLC29,229$157K0.0%N/A0.222%
(Data available from 1/1/2016 forward)

EDSA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of EDSA shares?

During the previous two years, the following institutional investors and hedge funds held shares of Edesa Biotech shares: Velan Capital Investment Management LP ($1.68M), Stonepine Capital Management LLC ($1.68M), Nantahala Capital Management LLC ($1.53M), CM Management LLC ($385K), and Citadel Advisors LLC ($70K), Two Sigma Securities LLC ($26K).Learn more on Edesa Biotech's institutional investors.

What percentage of Edesa Biotech's stock is owned by institutional investors?

5.50% of Edesa Biotech's stock is owned by institutional investors. Learn more on EDSA's institutional investor holdings.

Which institutional investors have been buying Edesa Biotech's stock?

The following institutional investors have purchased Edesa Biotech's stock in the last 24 months: Stonepine Capital Management LLC ($687.50K), Velan Capital Investment Management LP ($687.50K), Nantahala Capital Management LLC ($625K), CM Management LLC ($120.60K), Citadel Advisors LLC ($40.94K), and Two Sigma Securities LLC ($15.31K).

How much institutional buying is happening at Edesa Biotech?

Institutional investors have bought a total of 2,084,257 shares in the last 24 months. This purchase volume represents approximately $5.09M in transactions.



This page (NASDAQ:EDSA) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners